EMEA-000452-PIP02-10-M05

Key facts

Invented name
  • Cialis
  • Adcirca (previously Tadalafil Lilly)
  • Adcirca
Active substance
tadalafil
Therapeutic area
Cardiovascular diseases
Decision number
P/0395/2018
PIP number
EMEA-000452-PIP02-10-M05
Pharmaceutical form(s)
  • Film-coated tablet
  • Oral suspension
Condition(s) / indication(s)
Treatment of pulmonary arterial hypertension
Route(s) of administration
  • Oral use
  • Gastric use
Contact for public enquiries
Eli Lilly and Company Limited

Tel. +44 (0)1276 483000
E-mail: eu_paediatric@lilly.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating